Medicare Enrolled

Dr. Farhan Mohammad, M.D.

Internal Medicine · Mckinney, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
4201 MEDICAL CENTER DR STE 180, Mckinney, TX 75069
3475925112
In practice since 2011 (14 years)
NPI: 1184902512 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mohammad from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mohammad? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mohammad

Dr. Farhan Mohammad is an internal medicine specialist in Mckinney, TX, with 14 years of NPI registration. Based on federal Medicare data, Dr. Mohammad performed 71,223 Medicare services across 2,071 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mohammad received a total of $4,060 from 51 pharmaceutical and/or device companies across 198 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mohammad is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice ▲ Top 1% volume in TX $4,060 industry payments

Medicare Practice Summary

Medicare Utilization ↗
71,223
Medicare services
Top 1% in TX for internal medicine
2,071
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,087 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron sucrose injection (Venofer) 31,000 $0 $2
Anti-nausea injection (fosaprepitant) 13,800 $0 $5
Pembrolizumab injection (Keytruda) 12,400 $43 $137
Dexamethasone injection (steroid) 2,900 $0 $1
Immune globulin infusion (Octagam) 2,050 $33 $233
Injection, granisetron hydrochloride, 100 mcg 1,520 $0 $24
Anti-nausea injection (Aloxi/palonosetron) 1,030 $1 $114
Complete blood count (CBC) with differential 743 $8 $36
Office visit, established patient (30-39 min) 698 $94 $368
Injection of additional new drug or substance into vein 560 $12 $108
Comprehensive metabolic blood panel 540 $10 $64
Hospital follow-up visit, moderate complexity 442 $60 $247
Blood draw (venipuncture) 416 $8 $20
Administration of chemotherapy into vein, 1 hour or less 413 $98 $707
Injection, fluorouracil, 500 mg 330 $2 $13
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 227 $48 $313
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 189 $22 $157
Initial hospital admission, high complexity 163 $132 $693
Injection, zoledronic acid, 1 mg 146 $7 $431
Drug injection, under skin or into muscle 142 $11 $96
Injection, diphenhydramine hcl, up to 50 mg 124 $1 $7
Ferritin level test (iron stores) 119 $13 $60
Iron level test 119 $6 $27
Iron binding capacity test 119 $9 $35
Irrigation of implanted venous access drug delivery device 103 $18 $114
Administration of additional new drug or substance into vein, 1 hour or less 96 $48 $344
Carcinoembryonic antigen (cea) protein level 83 $19 $99
Administration of chemotherapy into vein, each additional hour 83 $20 $161
New patient office visit (45-59 min) 64 $119 $565
Lactate dehydrogenase (enzyme) level 63 $6 $31
Unclassified drugs 52 $1 $8
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour 49 $15 $100
Office visit, established patient, complex (40-54 min) 42 $113 $496
Infusion, normal saline solution , 1000 cc 41 $2 $19
Nuclear medicine study from skull base to mid-thigh with ct scan 37 $1,112 $4,802
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 37 $90 $657
Reticulated (young) platelet measurement 35 $35 $143
Infusion, normal saline solution, sterile (500 ml = 1 unit) 35 $1 $19
Infusion into a vein for hydration, each additional hour 34 $10 $75
Injection of drug or substance into vein 34 $28 $247
Microscopic examination for white blood cells with manual cell count 30 $4 $22
Complete blood count (CBC), automated 30 $6 $34
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 29 $20 $128
Red blood count automated, with additional calculations 28 $5 $26
Initial hospital admission, moderate complexity 28 $83 $470
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.7% high complexity
90.6% medium
5.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$4,060
Total received (2018-2024)
Avg $580/year across 7 years
Top 19% in TX for internal medicine
51
Companies
198
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,022 (99.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$37 (0.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,277
2023
$1,327
2022
$335
2021
$170
2020
$156
2019
$514
2018
$280

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$523
E.R. Squibb & Sons, L.L.C.
$369
PFIZER INC.
$339
Novartis Pharmaceuticals Corporation
$272
GENZYME CORPORATION
$158
Gilead Sciences, Inc.
$157
Janssen Biotech, Inc.
$147
Incyte Corporation
$140
Merck Sharp & Dohme Corporation
$138
Medtronic, Inc.
$131
Celgene Corporation
$113
Daiichi Sankyo Inc.
$99
Myriad Genetic Laboratories, Inc.
$97
Tactile Systems Technology Inc
$85
Regeneron Healthcare Solutions, Inc.
$83
Astellas Pharma US Inc
$74
Seagen Inc.
$72
Rigel Pharmaceuticals, Inc.
$67
Genmab U.S., Inc.
$67
ARRAY BIOPHARMA INC
$62
Sirtex Medical Inc
$61
Merck Sharp & Dohme LLC
$60
Inari Medical, Inc.
$54
Pharmacosmos Therapeutics Inc.
$52
Alnylam Pharmaceuticals Inc.
$45
AVEO Pharmaceuticals, Inc.
$40
Janssen Pharmaceuticals, Inc
$39
Stemline Therapeutics Inc.
$38
PharmaEssentia USA Corporation
$34
Epizyme, Inc.,
$31
EMD Serono, Inc.
$28
Pharmacyclics LLC, an AbbVie Company
$27
Kite Pharma, Inc.
$25
MorphoSys, US Inc.
$23
Eisai Inc.
$23
Kyowa Kirin, Inc.
$21
ABBVIE INC.
$21
Dova Pharmaceuticals
$21
Secura Bio, Inc.
$20
Karyopharm Therapeutics Inc.
$19
Medtronic USA, Inc.
$19
Agios Pharmaceuticals, Inc.
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
GlaxoSmithKline, LLC.
$18
Blue Earth Diagnostics Limited
$18
Blueprint Medicines Corporation
$17
ADC Therapeutics America, Inc.
$16
Genentech USA, Inc.
$15
PUMA BIOTECHNOLOGY, INC.
$15
Acrotech Biopharma LLC
$14
Lilly USA, LLC
$13
Top 3 companies account for 30.3% of total payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · AYVAKIT · Avastin · Axumin · BELEODAQ · BESREMI · BOSULIF · CALQUENCE · CARVYKTI · COPIKTRA · CREON · CYRAMZA · DARZALEX · Doptelet · ELREXFIO · ENJAYMO · Enhertu · Epkinly · FLEXITOUCH · FLOWTRIEVER CATHETER · FOTIVDA · Flexitouch Plus · GILOTRIF · GIVLAARI · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KYPHON EXPRESS II KYPHOPAK TRAY · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · OJJAARA · OPDIVO · OSTEOCOOL RF ABLATION · OSTEOCOOL RF ABLATION SYSTEM · Orserdu · PADCEV · PIQRAY · PRECISETUMOR · Padcev · Pomalyst · Poteligeo · PreciseTumor · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · S · SARCLISA · SIR-Spheres Microspheres · TABRECTA · TAZVERIK · TEPMETKO · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Trodelvy · Vanflyta · XALKORI · XARELTO · XPOVIO · XTANDI · Xtandi · YERVOY · Yescarta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $6 per 100 Medicare services performed
Looking for an internal medicine specialist in Mckinney?
Compare internal medicine physicians in the Mckinney area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
1,028
Per 100K population
92.1
County median income
$117,588
Nearest hospital
MEDICAL CENTER OF MCKINNEY
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mohammad is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with low-engagement industry engagement in the top 19% of TX peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Mohammad experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Mohammad performed 31,000 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mohammad receive payments from pharmaceutical companies?
Yes. Dr. Mohammad received a total of $4,060 from 51 companies across 198 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mohammad's costs compare to other internal medicine physicians in Mckinney?
Dr. Mohammad's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mohammad) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →